Preparing Pediatric Practices to be Ready for the COVID-19 Vaccines
Early Monday morning, November 9th, Pfizer announced some positive results regarding their COVID-19 Vaccine they are developing with BioNTech. This vaccine candidate is a two-dose series. The phase III clinical trials involved over 40,000 patients. There is some data in the press release that based on exposing patients who received the vaccine to…